XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Costs and expenses:        
Research and development $ 24,084 $ 31,731 $ 96,203 $ 85,980
Selling, general and administrative 11,323 16,422 37,395 38,785
Total costs and expenses 35,407 48,153 133,598 124,765
Loss from operations (35,407) (48,153) (133,598) (124,765)
Interest expense (4,052) (7,916) (21,498) (23,781)
Interest and other income 2,346 4,413 9,008 12,913
Net loss from continuing operations (37,113) (51,656) (146,088) (135,633)
Net income from discontinued operations, net of tax 4,881 13,906 20,631 26,888
Net loss $ (32,232) $ (37,750) $ (125,457) $ (108,745)
Basic and diluted net income (loss) per share:        
Net loss from continuing operations (in dollars per share) $ (0.64) $ (0.82) $ (2.51) $ (2.16)
Net income from discontinued operations (in dollars per share) 0.08 0.22 0.36 0.43
Net loss (in dollars per share) $ (0.56) $ (0.6) $ (2.15) $ (1.73)
Weighted-average shares used to compute basic and diluted net income (loss) per share (in shares) 57,948,093 62,856,721 58,232,007 62,840,990